BioSpace News Archive

Biotech Bay

Shockwave Medical Launches New Coronary IVL Catheter Internationally and Enrolls First Patient in All-Female Empower Study

Shockwave Medical, Inc. (NASDAQ: SWAV) today announced the full commercial availability of the Shockwave C2+ Coronary Intravascular Lithotripsy (IVL) Catheter to treat severely calcified coronary artery disease in select international markets.

May 15, 2023
·
5 min read
Drug Development

Celldex Therapeutics Presents Positive Preclinical Data from TSLP/SCF Bispecific Antibody Program CDX-622 at IMMUNOLOGY2023™

Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced preclinical data from CDX-622, the Company’s bispecific antibody with dual targeting of the alarmin TSLP and stem cell factor (SCF), also known as KIT receptor ligand, developed from its bispecific antibody platform.

May 15, 2023
·
5 min read
Drug Development

Numab Therapeutics Announces First Subject Dosed in Phase 1 Clinical Study of NM26 Program

Numab Therapeutics AG announced that the first subject has been dosed in the Phase 1 clinical study of NM26-2198, a first-in-class bi-specific antibody for the treatment of moderate-to-severe atopic dermatitis.

May 15, 2023
·
5 min read
Policy

FDA Grants SiSaf’s Innovative siRNA Therapy SIS-101-ADO Orphan Drug Designation and Rare Pediatric Disease Designation for the Treatment of Autosomal Dominant Osteopetrosis

SiSaf Ltd, an RNA delivery and therapeutics company, announces that SIS-101-ADO, its siRNA therapeutic for patients with Autosomal Dominant Osteopetrosis Type 2, has been granted Orphan Drug Designation by the U.S. FDA.

May 15, 2023
·
4 min read
Business

NUCLIDIUM and PharmaLogic Form Strategic Partnership for Sustainable Development of Novel Copper-based Theranostics to Diagnose and Treat Solid Tumours

NUCLIDIUM and PharmaLogic Holdings announced that they have entered into a strategic collaboration agreement for the production and clinical supply of 61Cu in the United States to accelerate the development of NUCLIDIUM’s theranostic pipeline.

May 15, 2023
·
5 min read
Business

Science 37 Reports First Quarter 2023 Financial Results

Science 37 Holdings, Inc., the industry-leading Metasite™, reported its financial results for the quarter ended March 31, 2023.

May 15, 2023
·
15 min read
Business

Vivani Medical Reports First Quarter 2023 Financial Results and Provides Business Update

Vivani Medical, Inc. reported financial results for the first quarter and provided a business update.

May 15, 2023
·
10 min read
Rona Therapeutics and Keymed Biosciences Announce Collaboration to Discover and Develop First-in-class siRNA Therapeutics for Glomerulonephritis

Rona Therapeutics, Inc and Keymed Biosciences, announced a collaboration to jointly discover and develop first-in-class siRNA therapeutics for Glomerulonephritis.

May 15, 2023
·
3 min read
Relief Therapeutics Announces Swissmedic Approval and Operation of New Good Manufacturing Practice-Compliant Laboratory

RELIEF THERAPEUTICS Holding SA announced its new state-of-the-art laboratory has been audited and approved by the Swiss Agency for Therapeutic Products and meets Good Manufacturing Practice standards.

May 15, 2023
·
5 min read
Business

OMass Therapeutics Announces Appointment of New Board Chair and Series B Extension

OMass Therapeutics announces the appointment of Jim Geraghty as chairman of its board of directors and an additional investment of £10 million from new investor British Patient Capital in a Series B extension, bringing the total raised in this round to £85.5 million.

May 15, 2023
·
6 min read